Exablate
Device Neurology
General payments
$1,967,051
Research payments
$5,956,331
Through program year 2025, $1,967,051 in general payments and $5,956,331 in research payments were reported against Exablate (Neurology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $185,010 | 1,857 |
| 2025 | Research | $943,461 | 110 |
| 2023 | General | $635,868 | 720 |
| 2023 | Research | $1,709,104 | 152 |
| 2022 | General | $649,427 | 492 |
| 2022 | Research | $3,297,411 | 129 |
| 2021 | General | $496,747 | 99 |
| 2021 | Research | $6,355 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 62 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,168 general · 392 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.